High Drug Prices: How We Got Here and How We Achieve Affordability

The pharmacy industry is at a pivotal moment. Rising costs, the affordability of specialty drugs, and middlemen who do not always have their clients’ best interest in mind have created a complex problem. Now is the time to streamline the process and provide the groups that are funding the cost of drugs with a long overdue lead role in the negotiating process. Read more about the state of the industry in this Pharmacy Times article by Thatcher Sloan, Vice President, Practice Leader, RxBenefits.

Share It